Comment on

• Fourth-generation fluoroquinolones in tuberculosis.

  Rieder HL. Rieder HL. Lancet. 2009 Apr 4;373(9670):1148-9. doi: 10.1016/S0140-6736(09)60559-6. Lancet. 2009. PMID: 19345815 No abstract available.
• Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

  Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. Conde MB, et al. Lancet. 2009 Apr 4;373(9670):1183-9. doi: 10.1016/S0140-6736(09)60333-0. Lancet. 2009. PMID: 19345831 Free PMC article. Clinical Trial.